1H3 — Clearbridge Health Balance Sheet
0.000.00%
- SG$8.59m
- SG$10.60m
- SG$9.93m
Annual balance sheet for Clearbridge Health, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14.6 | 6.05 | 4.48 | 4.29 | 1.25 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8.25 | 3.43 | 2.84 | 3.18 | 3.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 31.1 | 10.8 | 8.51 | 7.99 | 5.45 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.47 | 2.1 | 3.27 | 2.07 | 1.71 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 82.7 | 58.2 | 23.9 | 21.2 | 9.84 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.2 | 5.1 | 4.91 | 9.19 | 3.61 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 30.5 | 16.8 | 13.7 | 12 | 6.39 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 52.2 | 41.4 | 10.2 | 9.21 | 3.45 |
| Total Liabilities & Shareholders' Equity | 82.7 | 58.2 | 23.9 | 21.2 | 9.84 |
| Total Common Shares Outstanding |